1. Home
  2. LTRX vs IMUX Comparison

LTRX vs IMUX Comparison

Compare LTRX & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRX
  • IMUX
  • Stock Information
  • Founded
  • LTRX 1989
  • IMUX 2016
  • Country
  • LTRX United States
  • IMUX United States
  • Employees
  • LTRX N/A
  • IMUX N/A
  • Industry
  • LTRX Computer Communications Equipment
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRX Telecommunications
  • IMUX Health Care
  • Exchange
  • LTRX Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • LTRX 112.3M
  • IMUX 100.0M
  • IPO Year
  • LTRX 2000
  • IMUX N/A
  • Fundamental
  • Price
  • LTRX $3.64
  • IMUX $1.00
  • Analyst Decision
  • LTRX Strong Buy
  • IMUX Strong Buy
  • Analyst Count
  • LTRX 5
  • IMUX 6
  • Target Price
  • LTRX $6.50
  • IMUX $12.67
  • AVG Volume (30 Days)
  • LTRX 390.5K
  • IMUX 853.7K
  • Earning Date
  • LTRX 02-06-2025
  • IMUX 02-20-2025
  • Dividend Yield
  • LTRX N/A
  • IMUX N/A
  • EPS Growth
  • LTRX N/A
  • IMUX N/A
  • EPS
  • LTRX N/A
  • IMUX N/A
  • Revenue
  • LTRX $161,719,000.00
  • IMUX N/A
  • Revenue This Year
  • LTRX N/A
  • IMUX N/A
  • Revenue Next Year
  • LTRX $11.70
  • IMUX N/A
  • P/E Ratio
  • LTRX N/A
  • IMUX N/A
  • Revenue Growth
  • LTRX 22.12
  • IMUX N/A
  • 52 Week Low
  • LTRX $2.49
  • IMUX $0.97
  • 52 Week High
  • LTRX $6.95
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • LTRX 59.87
  • IMUX 34.82
  • Support Level
  • LTRX $3.54
  • IMUX $1.02
  • Resistance Level
  • LTRX $3.88
  • IMUX $1.18
  • Average True Range (ATR)
  • LTRX 0.21
  • IMUX 0.08
  • MACD
  • LTRX 0.06
  • IMUX -0.02
  • Stochastic Oscillator
  • LTRX 72.09
  • IMUX 0.00

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: